Your World of Legal Intelligence
 United Kingdom | +44 (0) 20 7284 8080

Endo Acquires Six Development-Stage, Ready-to-Use Injectable Product Candidates from Nevakar.

Document Cited in Related
Vincent

MANews-(C)2009-2022

Dublin-based specialty pharmaceutical company Endo International plc's (NASDAQ: ENDP) Endo Ventures Ltd. subsidiary has acquired six development-stage, ready-to-use injectable product candidates from Nevakar Injectables Inc., a subsidiary of US-based pharmaceutical company Nevakar, Inc, the company said.

The product candidates are in various stages of development, with the first launch expected in 2025.

With the acquisition, Endo controls all remaining development, approval, launch and commercialization activities for these product candidates.

Endo's Par Sterile Products business will commercialize the products in the United States.

Under the terms of the agreement, EVL purchased the six product candidates from Nevakar Injectables for a one-time payment of USD 35m.

The one-time payment is expected to be expensed immediately in the second quarter as acquired in-process research and development costs. This acquisition is separate from Endo's previously announced exclusive licensing agreement with Nevakar.

Ready-to-use, or RTU, products help streamline...

To continue reading

Request your trial
COPYRIGHT Normans Media Ltd.

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT